Isolation and identification of 1α-hydroxy-3-epi-vitamin D 3, a potent suppressor of parathyroid hormone secretion

Journal of Cellular Biochemistry

Volumn 96, Issue 3, 2005, Pages 569-578

  Brown, Alex J ^g   Ritter, Cynthia S ^g   Weiskopf, A S ^c   Vouros, P ^d   Sasso, Gino J ^e   Uskokovic, Milan R ^f   Wang, Guochun ^b   Reddy, Satyanarayana G ^a  

^a BROWN UNIVERSITY   (United States)

^b Brown University   (United States)

^c Cetek Corproation   (United States)

^d NORTHEASTERN UNIVERSITY   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

^f Bioxell Inc   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1 ,25(OH)2 3 epi D3; 1 ,25(OH)2D3; 1 OH 3 epi D3; 1 OHD3; C 3 epimerization pathway; Chronic renal failure; Metabolism; Parathyroid hormone

Indexed keywords

1ALPHA HYDROXY 3 EPI COLECALCIFEROL; ALFACALCIDOL; CALCIUM; COLECALCIFEROL DERIVATIVE; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D; COLECALCIFEROL; DRUG DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DRUG STRUCTURE; EPIMERIZATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE INHIBITION; HYDROXYLATION; HYPERCALCEMIA; KIDNEY FUNCTION; MALE; MASS SPECTROMETRY; NONHUMAN; OSTEOSARCOMA CELL; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SECONDARY HYPERPARATHYROIDISM; STRUCTURE ACTIVITY RELATION; VITAMIN D METABOLISM; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; FEMALE; HUMAN; METABOLISM; OSTEOSARCOMA; SECRETION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; UREMIA;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CHOLECALCIFEROL; FEMALE; HUMANS; MALE; MOLECULAR STRUCTURE; OSTEOSARCOMA; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; UREMIA;

EID: 27144453008     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20553     Document Type: Article

References (19)

1. 3: Its production and metabolism in primary human keratinocytes. Mol Cell Endocrinol 170:91-101.
2. Bischof MG, Siu-Caldera M-L, Weiskopf A, Vouros P, Cross HS, Peterlik M, Reddy GS. 1998. Differentiation-related pathways of 1 α,25- dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: Production of 1 α,25-dihydroxy-3epi-cholecalciferol. Exp Cell Res 241:194-201.
3. Brown AJ. 2000. Mechanisms for the selective actions of vitamin D analogues. Curr Pharm Design 6:701-716.
4. 3 is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 73:106-113.
5. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. 1999b. Decreased calcium sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int 55:1284-1292.
6. 3 regarding suppression of parathyroid hormone and calcemic action. Nephrol Dial Transpl 17(Suppl 10):41-45.
7. 3 produced in rat osteosarcoma cells (UMR 106). J Nutr Sci Vitaminol 47(2):108-115.
8. 3 and subsequently metabolized through C-1α or C-24 hydroxylation. J Biol Chem 279(16):15897-15907.
9. 3 metabolic pathway in cultured cell lines. Biol Pharm Bull 23(2):133-139.
10. 3 with an abbreviated side chain containing no hydroxyl. Proc Natl Acad Sci USA 101:6900-6904.
11. 3 through C-24 oxidation pathway. Biochemistry 28:1763-1769.
12. 3 in neonatal human keratinocytes. In: Norman AW, Bouillon R, Thomasett M, Editors. Vitamin D: A pluripotent steroid hormone: Structural studies, molecular endocrinology and clinical applications. New York: Walter de Gruyter. pp 172-173.
13. 3 through A-ring modification. In: Norman AW, Bouillon R, Thomasset M, Editors. Vitamin D, chemistry, biology, and clinical applications of the steroid hormone. Riverside: University of California, pp 139-146.
14. 3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway. Arch Biochem Biophys 383(2):197-205.
15. 3 in neonatal human keratinocytes. Steroids 66(3-5):441-450.
16. Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ. 2002. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res 17:2206-2213.
17. 3 in rats. FEBS Lett 448:278-282.
18. 3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): Existence of the C-3 epimerization pathway in ROS 17/ 2.8 cells in which the C-24 oxidation pathway is not expressed. Bone 24(5):457-463.
19. 2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Am J Kidney Dis 26:852-860.